Ignite Creation Date:
2025-12-24 @ 3:19 PM
Ignite Modification Date:
2026-02-20 @ 6:33 PM
Study NCT ID:
NCT05422092
Status:
UNKNOWN
Last Update Posted:
2022-09-21
First Post:
2022-06-09
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Canagliflozin on Liver Inflammation Damage in Type 2 Diabetes Patients With Nonalcoholic Fatty Liver Disease
Sponsor:
First Affiliated Hospital Xi'an Jiaotong University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-09-20
Start Date Type:
ESTIMATED
Primary Completion Date:
2023-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2023-12
Completion Date Type:
ESTIMATED
First Submit Date:
2022-06-09
First Submit QC Date:
None
Study First Post Date:
2022-06-16
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-09-18
Last Update Post Date:
2022-09-21
Last Update Post Date Type:
ACTUAL